GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-F) » Definitions » Price-to-Owner-Earnings

Mega Lifesciences PCL (BKK:MEGA-F) Price-to-Owner-Earnings : (As of May. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Price-to-Owner-Earnings?

As of today (2024-05-29), Mega Lifesciences PCL's share price is ฿0.00. Mega Lifesciences PCL does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Mega Lifesciences PCL's Price-to-Owner-Earnings or its related term are showing as below:

BKK:MEGA-F' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 14.09   Med: 22.7   Max: 56.44
Current: 17.45

During the past 13 years, the highest Price-to-Owner-Earnings of Mega Lifesciences PCL was 56.44. The lowest was 14.09. And the median was 22.70.


BKK:MEGA-F's Price-to-Owner-Earnings is ranked better than
67.39% of 417 companies
in the Drug Manufacturers industry
Industry Median: 26.99 vs BKK:MEGA-F: 17.45

As of today (2024-05-29), Mega Lifesciences PCL's share price is ฿0.00. Mega Lifesciences PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0.00. Therefore, Mega Lifesciences PCL's PE Ratio for today is N/A.

As of today (2024-05-29), Mega Lifesciences PCL's share price is ฿0.00. Mega Lifesciences PCL's EPS without NRI for the trailing twelve months (TTM) ended in was ฿0.00. Therefore, Mega Lifesciences PCL's PE Ratio without NRI for today is N/A.

During the past 13 years, Mega Lifesciences PCL's highest PE Ratio without NRI was 36.72. The lowest was 13.16. And the median was 24.61.


Mega Lifesciences PCL Price-to-Owner-Earnings Historical Data

The historical data trend for Mega Lifesciences PCL's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Price-to-Owner-Earnings Chart

Mega Lifesciences PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mega Lifesciences PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mega Lifesciences PCL's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Price-to-Owner-Earnings falls into.



Mega Lifesciences PCL Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mega Lifesciences PCL's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mega Lifesciences PCL  (BKK:MEGA-F) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Mega Lifesciences PCL Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL (BKK:MEGA-F) Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea,Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods as well as the provides distribution services relating to such products. The company's products portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purpose and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL (BKK:MEGA-F) Headlines

No Headlines